why choose us

First received: September 18, 2024

Clinical Trial: Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pulmonary Hypertension

Study Type: INTERVENTIONAL


Official Title: Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study

Brief Summary: This single-arm, retrospective study aims to evaluate the safety and efficacy of subcutaneous treprostinil as a bridge therapy for lung transplantation in patients with severe pulmonary hypertension (PH).A total of 46 patients with either pulmonary arterial hypertension (PAH) or chronic lung disease-associated PH (CLD-PH) were included, all of whom were referred for lung transplantation between January 1, 2015, and September 1, 2024.The study examines changes in clinical, functional, and hemodynamic parameters…

Read more